3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
27
Prostatic Neoplasms
26
Brain Neoplasms
23
Lung Neoplasms
17
Neoplasm Metastasis
15
Breast Neoplasms
12
Melanoma
9
Carcinoma, Renal Cell
8
Pancreatic Neoplasms
6
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
4
Urinary Bladder Neoplasms
3
Neoplasms
3
NSCLC
3
Meningioma
3
Gastrointestinal Neoplasms
3
Unresectable Locally Recurrent Rectal Cancer
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Epidural Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
Fluorouracil
13
pembrolizumab
12
Paclitaxel
12
Oxaliplatin
12
Leucovorin
9
Carboplatin
9
Capecitabine
8
Trastuzumab
7
Nivolumab
7
Cisplatin
7
Radiotherapy
6
Radiation
6
Taxes
5
Esophagectomy
5
Drug Therapy
5
Surgical Procedures, Operative
4
Specimen Handling
4
Irinotecan
4
trastuzumab deruxtecan
3
tislelizumab
3
patritumab deruxtecan
3
Radiotherapy, Intensity-Modulated
3
Proton Therapy
3
Immunotherapy
3
zanidatamab
2
ulixertinib
2
trastuzumab biosimilar HLX02
2
relatlimab
2
durvalumab
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Radiosurgery
×
90 days
×
Clear all
No trials found.